US6313096B1
(en)
|
1988-04-28 |
2001-11-06 |
Trigen Limited |
Inhibitors of trypsin-like enzymes
|
US5574014A
(en)
*
|
1988-04-28 |
1996-11-12 |
Thrombosis Research Institute |
Inhibitors of trypsin-like enzymes
|
US6825169B1
(en)
|
1991-10-22 |
2004-11-30 |
Trustees Of Tufts College |
Inhibitors of dipeptidyl-aminopeptidase type IV
|
MX9206628A
(es)
*
|
1991-11-22 |
1993-05-01 |
Boehringer Ingelheim Pharma |
Ester de prolinaboronato y metodo para su preparacion.
|
EP0636143B1
(en)
*
|
1992-04-16 |
1997-09-24 |
Zeneca Limited |
Alpha-aminoboronic acid peptides and their use as elastase inhibitors
|
FR2701951B1
(fr)
*
|
1993-02-24 |
1995-06-09 |
Adir |
Nouveaux derives peptidiques de l'acide boronique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
|
PL310940A1
(en)
*
|
1993-03-03 |
1996-01-08 |
Sandoz Ltd |
Organic compounds
|
AU6448794A
(en)
*
|
1993-03-24 |
1994-10-11 |
Du Pont Merck Pharmaceutical Company, The |
Boronic acid and ester inhibitors of thrombin
|
US5563127A
(en)
*
|
1993-03-24 |
1996-10-08 |
The Dupont Merck Pharmaceutical Company |
Boronic acid and ester inhibitors of thrombin
|
US6984627B1
(en)
|
1993-06-03 |
2006-01-10 |
Astrazeneca Ab |
Peptide derivatives
|
SE9301916D0
(sv)
*
|
1993-06-03 |
1993-06-03 |
Ab Astra |
New peptides derivatives
|
US5780631A
(en)
*
|
1993-06-03 |
1998-07-14 |
Astra Aktiebolag |
Starting materials in the synthesis of thrombin and kininogenase inhibitors
|
WO1995009859A1
(en)
*
|
1993-10-07 |
1995-04-13 |
The Du Pont Merck Pharmaceutical Company |
Boropeptide inhibitors of thrombin which contain a substituted pyrrolidine ring
|
IL111176A0
(en)
*
|
1993-10-07 |
1994-12-29 |
Du Pont Merck Pharma |
Dipeptide boronic acid inhibitors of trypsin-like enzymes and pharmaceutical compositions containing them
|
US5462964A
(en)
*
|
1993-10-20 |
1995-10-31 |
The Du Pont Merck Pharmaceutical Company |
Dipeptide boronic acid inhibitors of trypsin-like enzymes
|
IL111175A0
(en)
*
|
1993-10-07 |
1994-12-29 |
Du Pont Merck Pharma |
Electrophilic peptide analogs as inhibitors of trypsin-like serine proteases and pharmaceutical compositions containing them
|
US6060462A
(en)
*
|
1993-10-20 |
2000-05-09 |
Dupont Pharmaceuticals Company |
Electrophilic peptide analogs as inhibitors of trypsin-like enzymes
|
GB9401483D0
(en)
*
|
1994-01-26 |
1994-03-23 |
Sandoz Ltd |
Organic compounds
|
US5693617A
(en)
*
|
1994-03-15 |
1997-12-02 |
Proscript, Inc. |
Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
|
DE4421052A1
(de)
|
1994-06-17 |
1995-12-21 |
Basf Ag |
Neue Thrombininhibitoren, ihre Herstellung und Verwendung
|
FR2721611B1
(fr)
*
|
1994-06-22 |
1996-09-27 |
Adir |
Nouveaux dérivés peptidiques de l'acide boronique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent .
|
US5510369A
(en)
*
|
1994-07-22 |
1996-04-23 |
Merck & Co., Inc. |
Pyrrolidine thrombin inhibitors
|
US6083903A
(en)
|
1994-10-28 |
2000-07-04 |
Leukosite, Inc. |
Boronic ester and acid compounds, synthesis and uses
|
SE9404196D0
(sv)
*
|
1994-12-02 |
1994-12-02 |
Astra Ab |
New antithrombotic formulation
|
JPH11500120A
(ja)
*
|
1995-02-17 |
1999-01-06 |
ビーエーエスエフ アクチェンゲゼルシャフト |
新規なトロンビンインヒビター
|
US5629324A
(en)
*
|
1995-04-10 |
1997-05-13 |
Merck & Co., Inc. |
Thrombin inhibitors
|
EP0846682B9
(en)
|
1995-07-26 |
2003-05-14 |
Mitsubishi Chemical Corporation |
Penicillaminamide derivatives
|
GB9515489D0
(en)
*
|
1995-07-28 |
1995-09-27 |
Sandoz Ltd |
Organic compounds
|
AR005245A1
(es)
*
|
1995-12-21 |
1999-04-28 |
Astrazeneca Ab |
Prodrogas de inhibidores de trombina, una formulación farmaceutica que las comprende, el uso de dichas prodrogas para la manufactura de un medicamento y un procedimiento para su preparacion
|
FR2745288B1
(fr)
*
|
1996-02-27 |
1998-04-17 |
Adir |
Nouveaux derives de l'acide boronique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
US5965532A
(en)
*
|
1996-06-28 |
1999-10-12 |
Trustees Of Tufts College |
Multivalent compounds for crosslinking receptors and uses thereof
|
US6004955A
(en)
*
|
1996-08-15 |
1999-12-21 |
Dupont Pharmaceuticals Company |
Cyclic carbamates and isoxazolidines as IIb/IIIa antagonists
|
US6194435B1
(en)
|
1996-10-11 |
2001-02-27 |
Cor Therapeutics, Inc. |
Lactams as selective factor Xa inhibitors
|
US6369080B2
(en)
|
1996-10-11 |
2002-04-09 |
Cor Therapeutics, Inc. |
Selective factor Xa inhibitors
|
US6262047B1
(en)
|
1996-10-11 |
2001-07-17 |
Cor Therapeutics, Inc. |
Selective factor Xa inhibitors
|
EP0932615A1
(en)
*
|
1996-10-11 |
1999-08-04 |
Cor Therapeutics, Inc. |
SELECTIVE FACTOR Xa INHIBITORS
|
US6063794A
(en)
|
1996-10-11 |
2000-05-16 |
Cor Therapeutics Inc. |
Selective factor Xa inhibitors
|
EP0932608A1
(en)
*
|
1996-10-11 |
1999-08-04 |
Cor Therapeutics, Inc. |
SELECTIVE FACTOR Xa INHIBITORS
|
WO1998016524A1
(en)
*
|
1996-10-11 |
1998-04-23 |
Cor Therapeutics, Inc. |
HETEROCYCLIC DERIVATIVES AS FACTOR Xa INHIBITORS
|
US5798377A
(en)
*
|
1996-10-21 |
1998-08-25 |
Merck & Co., Inc. |
Thrombin inhibitors
|
AU741099B2
(en)
*
|
1997-04-14 |
2001-11-22 |
Millennium Pharmaceuticals, Inc. |
Selective factor Xa inhibitors
|
US6211183B1
(en)
|
1997-04-14 |
2001-04-03 |
Cor Therapeutics, Inc. |
Selective factor Xa inhibitors
|
AU6896298A
(en)
|
1997-04-14 |
1998-11-11 |
Cor Therapeutics, Inc. |
Selective factor xa inhibitors
|
US6369063B1
(en)
|
1997-04-14 |
2002-04-09 |
Cor Therapeutics, Inc. |
Selective factor Xa inhibitors
|
US6100234A
(en)
*
|
1997-05-07 |
2000-08-08 |
Tufts University |
Treatment of HIV
|
US6040145A
(en)
|
1997-05-07 |
2000-03-21 |
Tufts University |
Potentiation of the immune response
|
HUP0003906A2
(hu)
|
1997-06-19 |
2001-05-28 |
Du Pont Pharmaceuticals Co. |
Xa faktort gátló hatású heterociklusos vegyületek és ezeket tartalmazó gyógyszerkészítmények
|
US6218382B1
(en)
|
1997-08-11 |
2001-04-17 |
Cor Therapeutics, Inc |
Selective factor Xa inhibitors
|
US6333321B1
(en)
|
1997-08-11 |
2001-12-25 |
Cor Therapeutics, Inc. |
Selective factor Xa inhibitors
|
US6228854B1
(en)
|
1997-08-11 |
2001-05-08 |
Cor Therapeutics, Inc. |
Selective factor Xa inhibitors
|
AU743996B2
(en)
|
1997-09-29 |
2002-02-14 |
Point Therapeutics, Inc. |
Stimulation of hematopoietic cells in vitro
|
CA2317761A1
(en)
|
1998-01-26 |
1999-07-29 |
Basf Aktiengesellschaft |
Thrombin inhibitors
|
JP2003504301A
(ja)
|
1998-04-01 |
2003-02-04 |
ブリストル−マイヤーズ スクイブ ファーマ カンパニー |
インテグリンアンタゴニスト
|
WO1999056753A1
(en)
|
1998-05-04 |
1999-11-11 |
Point Therapeutics, Inc. |
Hematopoietic stimulation
|
CA2334155C
(en)
|
1998-06-05 |
2005-04-19 |
Point Therapeutics, Inc. |
Cyclic boroproline compounds
|
US6979697B1
(en)
|
1998-08-21 |
2005-12-27 |
Point Therapeutics, Inc. |
Regulation of substrate activity
|
WO2000039102A1
(en)
|
1998-12-23 |
2000-07-06 |
Du Pont Pharmaceuticals Company |
THROMBIN OR FACTOR Xa INHIBITORS
|
US6890904B1
(en)
|
1999-05-25 |
2005-05-10 |
Point Therapeutics, Inc. |
Anti-tumor agents
|
WO2002048157A2
(en)
*
|
2000-12-13 |
2002-06-20 |
Bristol-Myers Squibb Pharma Company |
Imidazolidinones and their related derivatives as hepatitis c virus ns3 protease inhibitors
|
JP2004516286A
(ja)
|
2000-12-18 |
2004-06-03 |
メルク エンド カムパニー インコーポレーテッド |
ベンジルアミン誘導体およびそれのトロンビン阻害薬としての使用
|
US6528503B2
(en)
|
2000-12-18 |
2003-03-04 |
Merck & Co., Inc. |
Thrombin inhibitors
|
US7144899B2
(en)
|
2001-02-09 |
2006-12-05 |
Merck & Co., Inc. |
Thrombin inhibitors
|
US6933290B2
(en)
|
2001-05-30 |
2005-08-23 |
Novartis Ag |
2-{N-(2-amino-3-(heteroaryl or aryl)propionyl)-aminoacyl}-amino}-alkylboronic acid derivatives
|
US7084134B2
(en)
|
2002-05-02 |
2006-08-01 |
Merk & Co., Inc. |
Thrombin inhibitors
|
EP1396270B1
(en)
|
2002-09-09 |
2006-05-10 |
Trigen Limited |
Boronic acid salts and use thereof in the preparation of medicaments for treating thrombosis
|
US7112572B2
(en)
|
2002-09-09 |
2006-09-26 |
Trigen Limited |
Multivalent metal salts of boronic acids
|
GB0507577D0
(en)
|
2005-04-14 |
2005-05-18 |
Novartis Ag |
Organic compounds
|
BR112018076614A2
(pt)
|
2016-06-21 |
2019-04-02 |
Orion Ophthalmology LLC |
derivados heterocíclicos de prolinamida
|
US10526315B2
(en)
|
2016-06-21 |
2020-01-07 |
Orion Ophthalmology LLC |
Carbocyclic prolinamide derivatives
|